Baird raises IQVIA Holdings price target to $249

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Baird analyst Eric Coldwell maintained an Outperform rating on IQVIA Holdings and raised the price target to $249 from $230, indicating a positive outlook for the NYSE-listed stock.

powered bylight_fuzz_icon
44451536

*this image is generated using AI for illustrative purposes only.

Baird analyst Eric Coldwell has maintained an Outperform rating on IQVIA Holdings and raised the price target to $249 from $230. The adjustment reflects a revised valuation outlook for the stock listed on the NYSE under the ticker IQV.

Rating and Target Details

The research note reinforces a positive stance on the company, signaling confidence in its future performance. The new price target of $249 represents an increase over the previous target of $230.

Metric Value
Rating Outperform
Previous Price Target $230
New Price Target $249
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove Baird to revise IQVIA's valuation outlook at this time?

How might IQVIA's recent strategic initiatives contribute to achieving the new $249 price target?

What are the potential risks that could hinder IQVIA from meeting this raised price target?

like18
dislike

Morgan Stanley downgrades IQVIA Holdings to Equal-Weight

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Morgan Stanley analyst Kallum Titchmarsh downgraded IQVIA Holdings from Overweight to Equal-Weight and lowered the price target to $200 from $225.

powered bylight_fuzz_icon
43249459

*this image is generated using AI for illustrative purposes only.

Morgan Stanley analyst Kallum Titchmarsh has downgraded IQVIA Holdings from Overweight to Equal-Weight. The firm also reduced the price target for the stock to $200 from the previous $225.

Rating and Target Changes

The downgrade reflects a revised outlook on the company's performance. The new price target of $200 represents a decrease from the prior target of $225.

Metric Previous New
Rating Overweight Equal-Weight
Price Target $225 $200
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors led to the revised outlook for IQVIA's performance?

How might this downgrade influence other analysts' ratings on IQVIA?

What are the potential market reactions to the lowered price target?

like16
dislike